TSX open
Loading markets…

Advertisement

PARTNER SPOTLIGHT

CIBC Investor's Edge

Get 200 free trades when you open an eligible CIBC Investor's Edge account.

  • 200 free stock & ETF trades
  • Unlimited commission-free trades on 180+ select ETFs
  • Offer ends September 30, 2026
Stocks/NASDAQ/PBLS

Parabilis Medicines, Inc. Common Stock (PBLS : NASDAQ)

Common Stock

$36.93

USD

-4.80 (-11.50%)

Last updated: 2026-09-21

Get PBLS alerts:

PBLS

Parabilis Medicines, Inc. Common Stock

Source:WealthAwesomeWealthAwesome
$1.20 (3.36%)
30 day period
$35.67$38.70$41.73Aug 10Aug 31Sep 21

Performance

1 Day

-11.50%

1 Week

+2.13%

1 Month

-6.17%

YTD

+41.87%

Key Statistics

Market Cap

$5.16B

52W High

$42.49

52W Low

$24.51

P/E Ratio

-

50 Day MA

$35.73

200 Day MA

$33.59

Beta

-

Dividend Yield

-

Advertisement

Technical Indicators

Price vs 50-Day SMA

Above 50 SMA

Price vs 200-Day SMA

Above 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
9/21/2026$41.58$42.31$34.72$36.93$36.931,704,289
9/18/2026$41.01$42.49$39.41$41.73$41.739,086,000
9/17/2026$37.51$42.22$37.35$40.88$40.881,093,176
9/16/2026$36.19$38.91$35.37$36.88$36.88970,996
9/15/2026$36.27$36.38$35.24$35.72$35.72446,230
9/14/2026$37.06$37.58$35.59$36.16$36.16482,361
9/11/2026$36.90$37.74$36.44$36.88$36.88364,814
9/10/2026$38.76$38.77$36.13$36.32$36.32680,800
9/9/2026$39.77$40.13$38.33$38.76$38.76501,200
9/8/2026$40.97$41.05$39.07$39.77$39.77564,000

Analyst Price Targets

Based on analyst covering PBLS · as of Sep 17, 2026

📈

Wall Street analysts forecast PBLS stock price to rise 13.1% over the next 12 months.

Consensus

Moderately Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

US$41.75

+13.1% Upside

Current Price

US$36.93

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on PBLS's historical volatility

HistoricalForecast68%95%
US$19.92US$35.49US$51.06US$66.63US$82.20US$97.77TodayJun 17Aug 5Sep 21Nov 3Dec 17Jan 29

30-Day Vol

64.0%

Annualized

90-Day Vol

64.5%

Annualized

Trend (90d)

+50.0%

Annualized drift

90d Mean

US$44.15

Expected price

HorizonExpected68% Range (1σ)
30 trading daysUS$39.19US$31.42US$48.89
60 trading daysUS$41.60US$30.43US$56.86
90 trading daysUS$44.15US$30.11US$64.74

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Parabilis Medicines, Inc. Common Stock

Parabilis Medicines, Inc. operates as a clinical-stage biopharmaceutical company focused on developing helical peptide therapeutics for disease treatment. The company develops stabilized helical peptide therapeutics through its Helicon discovery platform, targeting proteins that are traditionally considered undruggable. Its pipeline includes functional inhibitors of intracellular protein-protein interactions, targeted protein degraders, and targeted radiopharmaceuticals, with a lead clinical program, FOG-001, that acts as a TCF-blocking beta-catenin inhibitor for cancer treatment. The company integrates artificial intelligence and data science into drug discovery, trial design, and clinical strategy optimization. Parabilis Medicines serves clients in the healthcare and life sciences industries, including clinical research organizations and medical professionals involved in oncology and cancer treatment. The company was founded in 2015 and is based in Cambridge, Massachusetts.

Financials

Revenue (TTM)
$148,000
EBITDA
$-169.11M
Profit Margin
0.00%
ROE (TTM)
0.00%
EPS (Diluted)
-1.88
Book Value
8.48

Classification

Sector
Health Care
Industry
Biotechnology
Group
Pharmaceuticals, Biotechnology & Life Sciences

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About PBLS.US

Market movers

Recent NASDAQ movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
GRMLGreenland Mines Ltd$9.42+230.53%
GLNDGreenland Energy Company Common Stock$2.88+140.00%
BTTCBlack Titan Corporation$0.79+117.75%
VEEETwin Vee Powercats Co$17.24+100.93%
VRMEVerifyMe Inc$1.38+73.58%
AVATAvalanche Treasury Corporation Class A Common Stock$1.87+73.15%
INVInnventure, Inc.$0.88+47.26%
SVRNOceanPal Inc.$29.50+45.18%

PBLS.US news timeline

1 article covering PBLS.US, most recent first

Latest

Why Parabilis Medicines, Inc. Common Stock stock plummeted yesterday

Stocks

Advertisement